Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
KKR Genetic Disorder L.P.
10% owner at BridgeBio Pharma. Filing since 1 Jul 2019.
CIK 0001780408
Company
Date
Role
Action
Shares
Amount
Of holding
BBIO
BridgeBio Pharma, Inc.
12 May 2025
10% owner
Sold at will
6,000,000
$205.20M
31.2%
BBIO
BridgeBio Pharma, Inc.
5 Mar 2025
10% owner
Sold at will
6,000,000
$197.76M
23.8%
BBIO
BridgeBio Pharma, Inc.
13 Sep 2024
10% owner
Sold at will
5,800,000
$149.35M
18.7%
BBIO
BridgeBio Pharma, Inc.
17 Feb 2021
10% owner
Sold, plan not stated
3,450,000
$208.62M
10.0%
BBIO
BridgeBio Pharma, Inc.
28 May 2020
10% owner
Sold, plan not stated
2,389,690
$79.79M
6.5%
BBIO
BridgeBio Pharma, Inc.
1 Jul 2019
10% owner
Bought
2,647,100
$45.00M
7.7%
6 decisions on file.
